IMAX CORP
▲ 0 upgrades / ▼ 0 downgrades / 5 reiterations from 5 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 14, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Oct 14, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Oct 8, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Oct 7, 2026 | StoneX | maintain | Buy → Buy | — | — |
| Sep 24, 2026 | Morgan Stanley | initiate | — → Overweight | — | 54% |
| Sep 9, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Sep 4, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Sep 3, 2026 | Roth Capital | maintain | Buy → Buy | — | 53% |
| Sep 2, 2026 | Macquarie | maintain | Outperform → Outperform | — | 56% |
| Aug 24, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Aug 19, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Aug 10, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Jul 24, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Jul 24, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 24, 2026 | Roth Capital | maintain | Buy → Buy | — | 53% |
| Jul 24, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Jul 24, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 24, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jul 24, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Jul 20, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Jul 16, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | — | 54% |
| Jul 8, 2026 | Macquarie | maintain | Outperform → Outperform | — | 56% |
| May 22, 2026 | Benchmark | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | Macquarie | maintain | Outperform → Outperform | — | 56% |
| May 1, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| May 1, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Apr 23, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Apr 20, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Apr 8, 2026 | Seaport Global | maintain | Buy → Buy | — | 51% |
| Mar 2, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Feb 26, 2026 | Macquarie | maintain | Outperform → Outperform | $45 | 56% |
| Feb 26, 2026 | JP Morgan | maintain | Overweight → Overweight | $48 | 54% |
| Feb 26, 2026 | Benchmark | maintain | Buy → Buy | $44 | 54% |
| Feb 26, 2026 | Rosenblatt | maintain | Buy → Buy | $47 | 55% |
| Feb 24, 2026 | Rosenblatt | maintain | Buy → Buy | $47 | 55% |
| Feb 23, 2026 | Wedbush | reiterate | Outperform → Outperform | $46 | 58% |
| Jan 26, 2026 | Barrington Research | maintain | Outperform → Outperform | $42 | 56% |
| Jan 15, 2026 | Macquarie | maintain | Outperform → Outperform | $44 | 56% |
| Dec 18, 2025 | Wells Fargo | maintain | Overweight → Overweight | $47 | 54% |
| Dec 15, 2025 | JP Morgan | upgrade | Neutral → Overweight | $47 | 54% |
| Dec 8, 2025 | Wedbush | maintain | Outperform → Outperform | $46 | 58% |
| Dec 8, 2025 | Benchmark | maintain | Buy → Buy | $42 | 54% |
| Dec 8, 2025 | Barrington Research | maintain | Outperform → Outperform | $42 | 56% |
| Dec 8, 2025 | Rosenblatt | maintain | Buy → Buy | $47 | 55% |
| Nov 25, 2025 | Goldman Sachs | upgrade | Sell → Neutral | $34 | 54% |
| Oct 24, 2025 | Barrington Research | maintain | Outperform → Outperform | $37 | 56% |
| Oct 24, 2025 | Wells Fargo | maintain | Overweight → Overweight | $40 | 54% |
| Oct 24, 2025 | JP Morgan | maintain | Neutral → Neutral | $32 | 54% |
| Oct 24, 2025 | Rosenblatt | maintain | Buy → Buy | $42 | 55% |
No cross-platform signals in the last 90 days